Wei Niu

Title: Wei Niu - Innovator in Protein Kinase Inhibitors

Introduction

Wei Niu is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that target protein kinases. His work is crucial for advancing treatments for various cell proliferation disorders.

Latest Patents

Wei Niu holds a patent for isoxazolo[5,4-H]quinazoline compounds as protein kinase inhibitors. This patent describes a class of compounds represented by a general formula that can be utilized to treat cell proliferation disorders. These compounds are effective cyclin-dependent kinase (CDK) inhibitors, demonstrating broad-spectrum and strong inhibitory activity against CDK. The patent also includes a pharmaceutical composition comprising the compound and a method for treating and/or preventing CDK-mediated diseases in subjects.

Career Highlights

Wei Niu is associated with Chengdu Cynogen Bio-Pharmaceutical Technology Co., Ltd., where he applies his expertise in biopharmaceutical research. His innovative work in developing kinase inhibitors has positioned him as a key figure in the industry.

Collaborations

Wei Niu collaborates with notable colleagues, including Hang Cheng and Weiyan Xiong. Their combined efforts contribute to the advancement of biopharmaceutical technologies and the development of new therapeutic solutions.

Conclusion

Wei Niu's contributions to the field of protein kinase inhibitors highlight his role as an influential inventor in biopharmaceuticals. His innovative compounds have the potential to significantly impact the treatment of cell proliferation disorders.